ESR1 and breast cancer: Recent studies noting the successes of anti-estrogen treatments to patients with mammary hyperplasia or ERα-positive breast cancer [1], [10] supports that the estrogen signaling pathway plays an important role in the occurrence of mammary hyperplasia and breast cancer.